课题基金 / 基金详情

Targeting BAX Oligomerization in Hematologic Disease

Targeting BAX Oligomerization in Hematologic Disease
血液疾病中的 BAX 寡聚化靶向治疗
批准号：
8327897
负责人：
Evripidis Gavathiotis
金额：
$24.9万
依托单位：
ALBERT EINSTEIN COLLEGE OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
项目状态：
已结题
起止时间：
2011-09-14 至 2014-07-31
来源：
https://reporter.nih.gov/project-details/8327897
关键词：
ApoptosisApoptoticBAX geneBCL1 OncogeneBiologyBlood CellsCell DeathCellsCellular StressCessation of lifeChemicalsChemistryCommitComplexCytosolDana-Farber Cancer InstituteDeath DomainDevelopmentDiseaseEnvironmentEquilibriumFacultyFamilyFundingGatekeepingGoalsHematological DiseaseHematologyHomoJob ApplicationKnowledgeLaboratoriesLifeMediatingMentorshipMitochondriaMolecularNMR SpectroscopyNOESYOuter Mitochondrial MembranePathogenesisPathway interactionsPatientsPediatric OncologyPhasePhysiologicalPositioning AttributePrincipal InvestigatorProcessPropertyProtein FamilyProteinsRelaxationResearchResourcesRoleSiteSolutionsStimulusStructureTextTherapeuticTrainingalpha helixbasecareercareer developmentconformerdirect applicationinhibitor/antagonistinsightmedical schoolsmultidisciplinarymutantnovelprematureprogramsprotein structure functionquantumskillsstructural biologytool

项目成果

Evripidis Gavathiotis的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Allosteric inhibitors targeting oncogenic BRAF V600E dimers
Allosteric inhibitors targeting oncogenic BRAF V600E dimers
Allosteric inhibitors targeting oncogenic BRAF V600E dimers
Allosteric inhibitors targeting oncogenic BRAF V600E dimers
海外基金